First National Bank of Omaha reduced its position in shares of Medtronic PLC (NYSE:MDT) by 14.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 138,326 shares of the medical technology company’s stock after selling 23,236 shares during the period. Medtronic PLC accounts for 0.9% of First National Bank of Omaha’s portfolio, making the stock its 27th largest position. First National Bank of Omaha’s holdings in Medtronic PLC were worth $11,951,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Franklin Street Advisors Inc. NC increased its position in shares of Medtronic PLC by 19.1% in the second quarter. Franklin Street Advisors Inc. NC now owns 92,478 shares of the medical technology company’s stock worth $8,024,000 after buying an additional 14,814 shares during the period. Webster Bank N. A. boosted its stake in Medtronic PLC by 0.6% in the second quarter. Webster Bank N. A. now owns 8,800 shares of the medical technology company’s stock worth $763,000 after buying an additional 51 shares in the last quarter. Perkins Coie Trust Co boosted its stake in Medtronic PLC by 0.9% in the second quarter. Perkins Coie Trust Co now owns 24,758 shares of the medical technology company’s stock worth $2,149,000 after buying an additional 210 shares in the last quarter. American National Bank boosted its stake in Medtronic PLC by 4.4% in the second quarter. American National Bank now owns 60,455 shares of the medical technology company’s stock worth $5,246,000 after buying an additional 2,545 shares in the last quarter. Finally, Chevy Chase Trust Holdings Inc. boosted its stake in Medtronic PLC by 1.0% in the second quarter. Chevy Chase Trust Holdings Inc. now owns 1,300,067 shares of the medical technology company’s stock worth $112,807,000 after buying an additional 12,703 shares in the last quarter. 80.95% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for Medtronic PLC (NYSE:MDT)

Medtronic PLC (NYSE:MDT) traded down 0.11% on Tuesday, hitting $73.91. 2,960,214 shares of the company were exchanged. The stock has a 50 day moving average of $81.50 and a 200 day moving average of $84.68. Medtronic PLC has a 52 week low of $71.03 and a 52 week high of $89.27. The company has a market capitalization of $102.00 billion, a price-to-earnings ratio of 24.61 and a beta of 1.01.

Medtronic PLC (NYSE:MDT) last announced its earnings results on Tuesday, November 22nd. The medical technology company reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.01. The business had revenue of $7.35 billion for the quarter, compared to the consensus estimate of $7.46 billion. Medtronic PLC had a net margin of 14.63% and a return on equity of 12.36%. Medtronic PLC’s quarterly revenue was up 4.1% on a year-over-year basis. During the same period last year, the firm posted $1.03 earnings per share. Analysts predict that Medtronic PLC will post $4.63 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “First National Bank of Omaha Has $11,951,000 Position in Medtronic PLC (MDT)” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of international trademark and copyright law. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2016/11/29/first-national-bank-of-omaha-has-11951000-position-in-medtronic-plc-mdt.html.

MDT has been the subject of a number of research reports. Zacks Investment Research upgraded shares of Medtronic PLC from a “hold” rating to a “buy” rating and set a $97.00 target price for the company in a research note on Tuesday, August 9th. Citigroup Inc. initiated coverage on shares of Medtronic PLC in a research note on Tuesday, August 23rd. They set a “buy” rating and a $102.00 target price for the company. Cowen and Company set a $94.00 target price on shares of Medtronic PLC and gave the stock a “buy” rating in a research note on Tuesday, August 23rd. Jefferies Group restated a “buy” rating and set a $93.00 target price on shares of Medtronic PLC in a research note on Thursday, August 25th. Finally, Credit Suisse Group AG restated an “outperform” rating and set a $92.00 target price on shares of Medtronic PLC in a research note on Thursday, August 25th. Seven analysts have rated the stock with a hold rating and twenty have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $88.19.

In other Medtronic PLC news, VP Richard Kuntz sold 25,199 shares of the stock in a transaction that occurred on Monday, September 26th. The shares were sold at an average price of $86.67, for a total transaction of $2,183,997.33. Following the transaction, the vice president now directly owns 149,425 shares in the company, valued at $12,950,664.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Omar Ishrak sold 61,925 shares of the stock in a transaction that occurred on Thursday, September 15th. The shares were sold at an average price of $84.93, for a total transaction of $5,259,290.25. Following the transaction, the chief executive officer now owns 565,916 shares in the company, valued at $48,063,245.88. The disclosure for this sale can be found here. 0.25% of the stock is currently owned by corporate insiders.

Medtronic PLC Company Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

5 Day Chart for NYSE:MDT

Receive News & Stock Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related stocks with our FREE daily email newsletter.